Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
ERIS Lifesciences Ltd
Industry : Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value(
)
540596
INE406M01024
189.2952734
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
ERIS
161.39
18762.02
EPS(TTM)
Face Value(
)
Div & Yield %:
8.54
1
0
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
1528.28
1340.37
1215.73
1108.83
1020.23
896.54
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1528.28
1340.37
1215.73
1108.83
1020.23
896.54
Other Income
34.83
17.26
28.99
10.00
14.73
32.50
Stock Adjustments
13.15
-8.50
-2.49
12.57
-17.47
13.40
Total Income
1576.26
1349.13
1242.23
1131.40
1017.49
942.44
EXPENDITURE :
Raw Materials
293.31
227.88
197.16
211.08
146.88
145.75
Power & Fuel Cost
4.46
4.41
4.01
3.89
4.54
3.34
Employee Cost
331.67
252.52
220.11
207.02
191.73
166.77
Other Manufacturing Expenses
16.80
11.50
7.47
7.16
10.62
4.85
Selling & Administrative Expenses
319.25
242.67
215.51
181.66
219.34
251.38
Miscellaneous Expenses
122.13
87.78
84.93
93.13
73.93
4.09
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1087.61
826.75
729.18
703.93
647.04
576.17
Operating Profit
488.64
522.38
513.04
427.47
370.44
366.27
Interest
57.42
20.81
3.05
0.94
1.97
22.90
Gross Profit
431.22
501.57
509.99
426.53
368.47
343.37
Depreciation
102.39
64.66
51.46
37.64
44.88
31.59
Profit Before Tax
328.83
436.91
458.53
388.89
323.59
311.78
Tax
57.64
76.50
80.17
70.18
57.49
68.87
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
-28.52
-37.59
-38.83
-31.90
-25.17
-42.47
Reported Net Profit
299.71
398.01
417.19
350.61
291.27
285.38
Extraordinary Items
2.79
5.17
-1.72
2.33
4.49
1.08
Adjusted Net Profit
296.92
392.84
418.91
348.28
286.78
284.30
Adjustment below Net Profit
-2.76
-0.15
-1.01
-1.28
-100.21
-0.10
P & L Balance brought forward
2190.21
1892.28
1557.74
1283.09
1139.01
853.73
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
99.93
81.65
74.68
46.98
0.00
P & L Balance carried down
2487.16
2190.21
1892.28
1557.74
1283.09
1139.01
Dividend
0.00
99.93
81.65
74.68
38.97
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
0.00
735.00
601.00
550.00
287.00
0.00
Dividend Per Share(Rs)
0.00
7.35
6.01
5.50
2.87
0.00
Earnings Per Share-Unit Curr
22.03
29.27
30.69
25.82
21.45
20.75
Earnings Per Share(Adj)-Unit Curr
22.03
29.27
30.69
25.82
21.45
20.75
Book Value-Unit Curr
185.55
163.39
141.11
116.03
95.72
84.06
Book Value(Adj)-Unit Curr
185.55
163.39
141.11
116.03
95.72
84.06